287 related articles for article (PubMed ID: 17426256)
1. Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis.
Boosani CS; Mannam AP; Cosgrove D; Silva R; Hodivala-Dilke KM; Keshamouni VG; Sudhakar A
Blood; 2007 Aug; 110(4):1168-77. PubMed ID: 17426256
[TBL] [Abstract][Full Text] [Related]
2. Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3.
Borza CM; Pozzi A; Borza DB; Pedchenko V; Hellmark T; Hudson BG; Zent R
J Biol Chem; 2006 Jul; 281(30):20932-20939. PubMed ID: 16731529
[TBL] [Abstract][Full Text] [Related]
3. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.
Sudhakar A; Nyberg P; Keshamouni VG; Mannam AP; Li J; Sugimoto H; Cosgrove D; Kalluri R
J Clin Invest; 2005 Oct; 115(10):2801-10. PubMed ID: 16151532
[TBL] [Abstract][Full Text] [Related]
4. Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosis.
Verma RK; Gunda V; Pawar SC; Sudhakar YA
PLoS One; 2013; 8(12):e80555. PubMed ID: 24324608
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific expression of the RGD-alpha3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice.
Miyoshi T; Hirohata S; Ogawa H; Doi M; Obika M; Yonezawa T; Sado Y; Kusachi S; Kyo S; Kondo S; Shiratori Y; Hudson BG; Ninomiya Y
FASEB J; 2006 Sep; 20(11):1904-6. PubMed ID: 16877525
[TBL] [Abstract][Full Text] [Related]
6. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.
Sudhakar A; Sugimoto H; Yang C; Lively J; Zeisberg M; Kalluri R
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4766-71. PubMed ID: 12682293
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression.
Sudhakar A; Boosani CS
Pharm Res; 2008 Dec; 25(12):2731-9. PubMed ID: 18551250
[TBL] [Abstract][Full Text] [Related]
8. Type IV collagen α1-chain noncollagenous domain blocks MMP-2 activation both in-vitro and in-vivo.
Sudhakar YA; Verma RK; Pawar SC
Sci Rep; 2014 Mar; 4():4136. PubMed ID: 24670518
[TBL] [Abstract][Full Text] [Related]
9. Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion.
Pedchenko V; Zent R; Hudson BG
J Biol Chem; 2004 Jan; 279(4):2772-80. PubMed ID: 14610079
[TBL] [Abstract][Full Text] [Related]
10. Selective binding of integrins from different renal cell types to the NC1 domain of alpha3 and alpha1 chains of type IV collagen.
Aggeli AS; Kitsiou PV; Tzinia AK; Boutaud A; Hudson BG; Tsilibary EC
J Nephrol; 2009; 22(1):130-6. PubMed ID: 19229828
[TBL] [Abstract][Full Text] [Related]
11. Complex interactions between the laminin alpha 4 subunit and integrins regulate endothelial cell behavior in vitro and angiogenesis in vivo.
Gonzalez AM; Gonzales M; Herron GS; Nagavarapu U; Hopkinson SB; Tsuruta D; Jones JC
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16075-80. PubMed ID: 12454288
[TBL] [Abstract][Full Text] [Related]
12. Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth.
Hamano Y; Kalluri R
Biochem Biophys Res Commun; 2005 Jul; 333(2):292-8. PubMed ID: 15979458
[TBL] [Abstract][Full Text] [Related]
13. Tetrastatin, the NC1 domain of the α4(IV) collagen chain: a novel potent anti-tumor matrikine.
Brassart-Pasco S; Sénéchal K; Thevenard J; Ramont L; Devy J; Di Stefano L; Dupont-Deshorgue A; Brézillon S; Feru J; Jazeron JF; Diebold MD; Ricard-Blum S; Maquart FX; Monboisse JC
PLoS One; 2012; 7(4):e29587. PubMed ID: 22539938
[TBL] [Abstract][Full Text] [Related]
14. T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy.
Wang F; Dong X; Xiu P; Zhong J; Wei H; Xu Z; Li T; Liu F; Sun X; Li J
Oncol Rep; 2015 Feb; 33(2):675-84. PubMed ID: 25483829
[TBL] [Abstract][Full Text] [Related]
15. Integrin-mediated interactions between primary/T-sv40 immortalized human glomerular epithelial cells and type IV collagen.
Krishnamurti U; Chen Y; Michael A; Kim Y; Fan WW; Wieslander J; Brunmark C; Rondeau E; Sraer JD; Delarue F; Tsilibary EC
Lab Invest; 1996 Mar; 74(3):650-7. PubMed ID: 8600316
[TBL] [Abstract][Full Text] [Related]
16. Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF.
da Silva RG; Tavora B; Robinson SD; Reynolds LE; Szekeres C; Lamar J; Batista S; Kostourou V; Germain MA; Reynolds AR; Jones DT; Watson AR; Jones JL; Harris A; Hart IR; Iruela-Arispe ML; Dipersio CM; Kreidberg JA; Hodivala-Dilke KM
Am J Pathol; 2010 Sep; 177(3):1534-48. PubMed ID: 20639457
[TBL] [Abstract][Full Text] [Related]
17. Targeting of the COX-2/PGE2 axis enhances the antitumor activity of T7 peptide
Yang J; Zhong J; Zhou M; Zhou Y; Xiu P; Liu F; Wang F; Li Z; Tang Y; Chen Y; Yao S; Huang T; Liu T; Dong X
Drug Deliv; 2021 Dec; 28(1):844-855. PubMed ID: 33928829
[TBL] [Abstract][Full Text] [Related]
18. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties.
Maeshima Y; Colorado PC; Kalluri R
J Biol Chem; 2000 Aug; 275(31):23745-50. PubMed ID: 10837460
[TBL] [Abstract][Full Text] [Related]
19. alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.
Nisato RE; Tille JC; Jonczyk A; Goodman SL; Pepper MS
Angiogenesis; 2003; 6(2):105-19. PubMed ID: 14739617
[TBL] [Abstract][Full Text] [Related]
20. Molecular Cloning and Functional Characterization of Mouse α3(IV)NC1.
Boosani CS; Sudhakar A
Clin Med Oncol; 2008; 2():73-81. PubMed ID: 21892268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]